InsidersTradesSigma
尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。
Explore the full record of transactions filed by Gallagher Kathleen P.. Officer active across 2 companies, notably Avidity Biosciences, Inc.. Aggregated, 11 disclosures have been published. Split: 0 buy · 3 sells. Total volume traded: €67k. History available since 6 January 2025. The latest transaction was filed on 20 April 2026 (Attribution). Regulator: SEC (Form 4). All data is accessible without signup.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
11 条申报中的 11 条
Kathleen P. Gallagher is Chief Program Officer at Avidity Biosciences, Inc. She has 7 filings in total. In the 7 recent filings available, covering the period from 2025-01-08 to 2025-09-02, there were EUR 0 of buys and EUR 43,191 of sells, and the modal transaction nature is option exercise.